WeylChem is investing about €15 million to upgrade glyoxal production at its site in Lamotte, France. A new plant, which will increase capacity by approximately a third, is expected to start operating in early 2024.
The WeylChem Group of companies consists of seven operating and two R&D sites in Europe and the USA as well as the global sales and marketing platform, WeylChem International.
